Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Josef Nickl Hui-Milt Fenni. Gunther Engelhardt Ernst Seeger Gunther V Frummlitz Wolfhart Engel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2362589Aexternal-prioritypatent/DE2362589A1/en
Priority claimed from DE19742450991external-prioritypatent/DE2450991A1/en
Application filed by Dr Karl Thomae GmbHfiledCriticalDr Karl Thomae GmbH
Application grantedgrantedCritical
Publication of AU7645074ApublicationCriticalpatent/AU7645074A/en
Publication of AU496033B2publicationCriticalpatent/AU496033B2/en
Antiphlogistic phenyl-alkyl or alkenyl ketones or carbinols - have superior activity to phenylbutazone and are used in arthritis and rheumatism treatment
Antiphlogistic phenyl-alkyl or alkenyl ketones or carbinols - have superior activity to phenylbutazone and are used in arthritis and rheumatism treatment